Sabeena Choudhary

101 Seguidores

10 SlideShares 101 Seguidores 104 Seguindos

10 SlideShares 101 Seguidores 104 Seguindos

percist recist lugano ind drug approval new drug development drug brca ovarian cancer paola trial solo 1 olaparib response evaluat response evaluation in cancer response eval in lymphoma lymphoma response assessment lymphoma response ann arbor costwolds response adr adverse drug reaction fda approval priority review fast track breakthrough approval accelerated drug approval phases clinical trial

Ver mais

Atividades
Sobre

phases of a clinical trial and accelerated drug

Há 2 anos • 168 Visualizações

Detection, reporting and monitoring of ad rs final ppt

Há 2 anos • 1147 Visualizações

lymphoma response

Há 2 anos • 312 Visualizações

Part 2 response in lymphomas

Há 2 anos • 98 Visualizações

Lymphoma staging and response evolution with current recommendations (2)

Há 2 anos • 157 Visualizações

Response assessment lymphomas

Há 2 anos • 43 Visualizações

RECIST

Há 2 anos • 1148 Visualizações

Role of olaparib in breast and ovarian cancers

Há 2 anos • 628 Visualizações

Drug dev approval

Há 2 anos • 114 Visualizações

HIDAC.pptx

Há 1 ano • 4 Visualizações

Part 2 response in lymphomas

Sabeena Choudhary • Há 2 anos

phases of a clinical trial and accelerated drug

Sabeena Choudhary • Há 2 anos

Drug dev approval

Sabeena Choudhary • Há 2 anos

RECIST

Sabeena Choudhary • Há 2 anos

High-Yield Internal Medicine Board Review Pearls

Knowmedge • Há 10 anos

percist recist lugano ind drug approval new drug development drug brca ovarian cancer paola trial solo 1 olaparib response evaluat response evaluation in cancer response eval in lymphoma lymphoma response assessment lymphoma response ann arbor costwolds response adr adverse drug reaction fda approval priority review fast track breakthrough approval accelerated drug approval phases clinical trial

Ver mais